Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,499,870
-$399,461 QoQ
Shares Held
62,287
-7.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,093
of 2,821 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgewater Advisors Inc. holds $24,557,436 across 14 Drug Manufacturers - General names. PFE ranks #7 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,989 | $5,838,516 | |
| 2 | LLY |
ELI LILLY & Co
|
3,983 | $4,777,330 | |
| 3 | MRK |
Merck & Co., Inc.
|
23,905 | $3,071,792 | |
| 4 | ABBV |
AbbVie Inc.
|
9,702 | $2,441,411 | |
| 5 | AMGN |
Amgen Inc
|
5,459 | $1,976,813 | |
| 6 | NVS |
Novartis AG
|
10,369 | $1,625,029 | |
| 7 | PFE |
Pfizer Inc
This page
|
62,287 | $1,499,870 | |
| 8 | AZN |
Astrazeneca PLC
|
4,442 | $842,292 |
All Filings in PFE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,499,870 | 62,287 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,899,331 | 67,640 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,623,231 | 65,190 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,686,648 | 66,195 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,569,612 | 64,753 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,662,126 | 65,593 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,748,300 | 65,899 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,987,483 | 68,676 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,923,680 | 68,752 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,775,250 | 63,973 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,981,817 | 68,837 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,277,352 | 68,657 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,529,929 | 68,973 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $2,817,525 | 69,057 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $3,544,475 | 69,174 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $3,408,553 | 77,892 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $3,529,482 | 67,318 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,474,698 | 67,118 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $3,953,633 | 66,954 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,868,680 | 66,698 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $2,611,658 | 66,692 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,381,180 | 65,724 | Shares | Sole | 2021-05-20 | |
| No filing history on record for this holder in this stock. | ||||||